
Takeda’s Orzeyful, the first orexin agonist for narcolepsy type 1, is now available in the U.S. at a whole acquisition list price of $16,500 per 60-tablet bottle.
A review of agents in late-stage development for the treatment of atherosclerosis and thrombosis (June 2006).






